Get the Stockscreener App
0.6292
6.20%
-0.0416
Health In Tech Inc Stock (HIT) Forecast
The Health In Tech Inc (HIT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.2761, representing a +102.81% increase from the current price of $0.6292. The highest analyst price target is $2.2591, and the lowest is $0.2931.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HIT Price Target
Average 1.7428
(+176.99% Upside)
Is Health In Tech Inc (HIT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.14 | Buy |
| STOCH(9,6) | 25.16 | Neutral |
| STOCHRSI(14) | 3.4023 | Buy |
| MACD(12,26) | -0.0676 | Sell |
| ADX(14) | 39.81 | Sell |
| William %R | -97.28 | Buy |
| CCI(14) | -120.33 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7361
Sell
|
0.7224
Sell
|
| MA20 |
0.7913
Sell
|
0.7772
Sell
|
| MA50 |
0.9075
Sell
|
0.8797
Sell
|
| MA100 |
0.9772
Sell
|
0.9997
Sell
|
| MA200 |
1.2063
Sell
|
1.2381
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, HIT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on HIT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.14 indicates that HIT is oversold. This indicates that HIT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 25.16 indicates that HIT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.4023 indicates that HIT is oversold. This suggests that HIT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 39.81 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -120.33 indicates that HIT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term HIT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Health In Tech Inc financial reports and earnings history, Health In Tech Inc (HIT) stock could reach $3.2146 by 2030, $16.81 by 2040 and $31.74 by 2050. See the projected annual prices until 2050 of the Health In Tech Inc stock below:
- Health In Tech Inc (HIT) is expected to reach an average price of $15.25 in 2035, with a high prediction of $16.65 and a low estimate of $15.87. This indicates an $2,324% rise from the last recorded price of $0.6292.
- Health In Tech Inc (HIT) stock is projected to chart a bullish course in 2040, with an average price target of $15.84, representing an $2,417% surge from its current level. The forecast ranges from a conservative $16.03 to a sky-high $16.81.
- Our analysts predict Health In Tech Inc (HIT) to jump 6,494% by 2045, soaring from $4.9987 to an average price of $41.49, potentially reaching $41.30. While $4.9987 is the low estimate, the potential upside is significant.
- Health In Tech Inc (HIT) stock is expected to climb by 2050, reaching an average of $30.83, a $4,800% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.74 and $30.91, respectively, highlighting the market's uncertainty.
Health In Tech Inc Stock (HIT) Year by Year Forecast
Health In Tech Inc Stock (HIT) Price Forecast for 2026
The predicted value for Health In Tech Inc (HIT) in 2026 is set at an average of $1.7384. Estimates vary from a peak of $3.2223 to a trough of $0.2545, indicating an +176.29% surge from the present price of $0.6292.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.1077 | $0.2931 | $2.2591 | +76.05% |
| December, 2026 | $2.8523 | $0.9064 | $3.2223 | +353.33% |
Health In Tech Inc Stock (HIT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Health In Tech Inc (HIT) is $1.7428, with a high forecast of $3.463 and a low forecast of $0.0226. This indicates an +176.99% increase from the last price of $0.6292.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4813 | $3.4729 | $3.463 | +453.29% |
| February, 2027 | $3.3243 | $3.3681 | $3.3644 | +428.34% |
| March, 2027 | $3.1461 | $3.1783 | $3.281 | +400.02% |
| April, 2027 | $3.0163 | $3.0695 | $3.0766 | +379.39% |
| May, 2027 | $2.2872 | $2.4472 | $2.7106 | +263.52% |
| June, 2027 | $0.8126 | $1.3426 | $1.2699 | +29.15% |
| July, 2027 | $0.408 | $0.3653 | $0.7347 | -35.16% |
| August, 2027 | $0.4253 | $0.0564 | $0.6793 | -32.41% |
| September, 2027 | $0.1401 | $0.0226 | $1.1139 | -77.73% |
| October, 2027 | $1.1155 | $0.1565 | $1.0041 | +77.29% |
| November, 2027 | $0.8522 | $0.9222 | $1.3682 | +35.44% |
| December, 2027 | $0.8376 | $0.8236 | $0.7476 | +33.12% |
Health In Tech Inc Stock (HIT) Price Forecast for 2028
In 2028, Health In Tech Inc (HIT) is projected to reach an average price of $1.915, with a high projection of $3.8254 and a low estimate of $0.00467. This indicates an +204.36% rise from the last price of $0.6292.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6843 | $0.9543 | $1.0043 | +8.76% |
| February, 2028 | $0.5497 | $0.3234 | $0.1207 | -12.64% |
| March, 2028 | $0.2851 | $0.4551 | $0.431 | -54.69% |
| April, 2028 | $0.0705 | $0.1305 | $0.1478 | -88.80% |
| May, 2028 | $0.3672 | $0.4671 | $0.4945 | -41.64% |
| June, 2028 | $0.2726 | $0.2826 | $0.2999 | -56.68% |
| July, 2028 | $0.0307 | $0.00929 | $0.1439 | -95.12% |
| August, 2028 | $0.0253 | $0.0183 | $0.0794 | -95.97% |
| September, 2028 | $0.08 | $0.0145 | $0.1462 | -87.29% |
| October, 2028 | $4.0134 | $0.00467 | $3.8254 | +537.86% |
| November, 2028 | $3.8992 | $4.0865 | $3.6911 | +519.70% |
| December, 2028 | $2.1299 | $2.7499 | $3.2895 | +238.51% |
Health In Tech Inc Stock (HIT) Price Forecast for 2029
The 2029 price forecast for Health In Tech Inc Stock (HIT) is $4.8857 on average, with a high prediction of $7.6061 and a low estimate of $2.1653. This represents an +676.49% increase from the previous price of $0.6292.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.683 | $2.1653 | $7.4134 | +1,121% |
| February, 2029 | $7.3691 | $7.4041 | $7.6061 | +1,071% |
| March, 2029 | $6.9271 | $7.1527 | $7.2773 | +1,001% |
| April, 2029 | $6.7616 | $6.8032 | $6.9103 | +974.64% |
| May, 2029 | $6.1982 | $6.2391 | $6.6479 | +885.09% |
| June, 2029 | $4.6699 | $5.2699 | $5.7445 | +642.19% |
| July, 2029 | $3.6033 | $3.5806 | $4.5726 | +472.68% |
| August, 2029 | $2.7141 | $2.8941 | $3.3087 | +331.35% |
| September, 2029 | $2.7148 | $2.4721 | $2.3368 | +331.47% |
| October, 2029 | $3.9583 | $2.9079 | $3.6783 | +529.10% |
| November, 2029 | $3.679 | $3.891 | $3.9264 | +484.72% |
| December, 2029 | $3.2225 | $3.1998 | $3.3823 | +412.16% |
Health In Tech Inc Stock (HIT) Price Forecast for 2030
Health In Tech Inc Stock (HIT) is expected to reach an average price of $4.5652 in 2030, with a high forecast of $8.5096 and a low forecast of $0.6208. This signifies an +625.55% surge from the last price of $0.6292.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2533 | $3.2102 | $3.2146 | +417.05% |
| February, 2030 | $2.234 | $2.3404 | $3.0159 | +255.06% |
| March, 2030 | $2.2848 | $2.3067 | $2.3321 | +263.12% |
| April, 2030 | $1.7882 | $1.8882 | $2.1388 | +184.21% |
| May, 2030 | $2.0369 | $1.7609 | $2.009 | +223.73% |
| June, 2030 | $1.6797 | $1.7971 | $1.8017 | +166.96% |
| July, 2030 | $1.2732 | $1.3032 | $1.5624 | +102.35% |
| August, 2030 | $1.024 | $1.064 | $1.0959 | +62.74% |
| September, 2030 | $0.7663 | $0.8247 | $0.9166 | +21.79% |
| October, 2030 | $0.5884 | $0.6376 | $0.6587 | -6.49% |
| November, 2030 | $8.6307 | $0.6208 | $8.5096 | +1,272% |
| December, 2030 | $7.2708 | $7.9208 | $7.8847 | +1,056% |
1.83%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):